Thyroid hormone transport in the serum of patients with thyrotoxic graves' disease before and after treatment

AUTOR(ES)

Braverman, Lewis E.

RESUMO

Multiple indices of thyroid hormone binding have been studied in sera obtained from patients with thyrotoxic Graves' disease, before and after treatment, and in sera from a group of carefully matched normal controls. Specimens from patients with thyrotoxicosis displayed a decrease in the thyroxine (T4)-binding capacities of T4-binding globulin (TBG) and T4-binding prealbumin (TBPA), an increase in serum protein-bound iodine (PBI), and an increase in both the proportion and absolute concentration of free T4. In addition, a smaller than normal proportion of 131I-labeled T3 was associated with TBG during filter paper electrophoresis. After treatment of thyroxicosis, the only residual abnormality detected was a very slight persistent decrease in the T4-binding capacity of TBPA, which did not appear to influence the overall thyroid hormone-plasma protein interaction significantly, regardless of whether this was assessed under basal conditions or after enrichment of specimens with stable T4. It is concluded that the persistent abnormalities in the peripheral metabolism of T4, previously reported to occur in some patients with treated Graves' disease, probably do not stem from residual abnormalities in the transport of T4 in the plasma but must arise from abnormalities in T4 accumulation or metabolism within the tissues themselves.

Documentos Relacionados

• Color Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease
• THE NATURE OF THE CIRCULATING THYROID HORMONE IN GRAVES' DISEASE 1
• CHARACTERIZATION OF THE LONG-ACTING THYROID STIMULATOR OF GRAVES' DISEASE*
• Triiodothyronine, Thyroxine, and Iodine in Purified Thyroglobulin from Patients with Graves' Disease
• Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.